Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.263NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.180NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.180NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.180NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.464NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.464NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.464NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.234NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.234NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.234NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.231NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.231NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.231NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.243NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.517NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.517NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.517NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.291NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.291NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.291NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.349NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.349NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.349NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.314NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.314NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.314NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.132NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.132NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.132NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.42NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.42NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used